Submit Deal

Michael Rockefeller

Founder at WOODLINE PARTNERS

Investor

Deal Bio

Total Deals16

Valued Deals16

Total Value£5,702M

Avg. Deal Size£356M

Market Context

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

Expertise

Key Relationships (16)

Sort

United States

Pharmaceuticals

MinorityAcquisitionVenture CapitalPrivatePrivate Equity

target

Kronos Bio

bidder

Perceptive Advisors

£118m

18 dealmakers

United States

Consumer Services: Other

MajorityMergerPrivate EquityAcquisitionDomesticPrivateReverse TakeoverDe-SPAC

target

Talkspace Network

bidder

Hudson Executive Investment Corp

£1,030m

64 dealmakers

United States

Medical Services

AcquisitionMajorityPrivateDomesticMergerDe-SPACReverse TakeoverPrivate Equity

target

SHARECARE

bidder

Koch Industries

£2,822m

60 dealmakers

United States

Online and Social Platforms

DomesticVenture CapitalMinorityAcquisitionPrivatePrivate Equity

target

PATREON

bidder

Tiger Global Management

£112m

9 dealmakers

United States

Biotechnology

Private EquityDe-SPACReverse TakeoverPrivateDomesticMergerAcquisitionMajority

target

Tango Therapeutics

bidder

Cormorant Asset Management

£257m

32 dealmakers

United States

Biotechnology

MinorityPrivatePrivate EquityCross BorderVenture CapitalAcquisition

target

Affinia Therapeutics

bidder

Casdin Capital

£80m

15 dealmakers

United Kingdom

Biotechnology

AcquisitionPrivateMajorityPrivate EquityCross Border

target

INIVATA

bidder

NEOGENOMICS

£281m

41 dealmakers

United States

Software

Cross BorderMinorityPrivate EquityVenture CapitalPrivateAcquisition

target

Kriya Therapeutics

bidder

Woodline Partners

£72m

14 dealmakers

United States

Biotechnology

Venture CapitalMinorityCross BorderPrivatePrivate EquityAcquisition

target

Lexeo Therapeutics

bidder

D1 Capital Partners

£72m

15 dealmakers

Japan

Publishing

Venture CapitalCross BorderMinorityPrivate EquityAcquisitionPrivate

target

SMARTNEWS

bidder

Green Co-invest

£166m

9 dealmakers

United States

Health Care Facilities

DomesticVenture CapitalAcquisitionPrivatePrivate EquityMinority

target

NEOGENOMICS

bidder

Avidity Partners

£144m

26 dealmakers

China

Pharmaceuticals

Venture CapitalAcquisitionMinorityCross BorderPrivate EquityPrivate

target

SHOUTI

bidder

Casdin Capital

£72m

20 dealmakers

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy